Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Merdad Parsey
Age : 58
Public asset : 1,224,205 USD
Country of residence : Unknown
Linked companies : Gilead Sciences, Inc. - Arcus Biosciences, Inc.

Biography of Merdad Parsey 
Dr. Merdad V. Parsey is an Independent Director at Arcus Biosciences, Inc. and a Chief Medical Officer at Gilead Sciences, Inc. He is on the Board of Directors at Arcus Biosciences, Inc. and Sagimet Biosciences, Inc. Dr. Parsey was previously employed as a Senior Medical Director by Regeneron Pharmaceuticals, Inc., a Senior Director-Medical Group by Genentech, Inc., an Associate Medical Director by Merck & Co., Inc., a Director-Critical Care Medicine by New York University School of Medicine, a Member by Roche Group, and a Senior Medical Director by Sunovion Pharmaceuticals, Inc. He received his doctorate degree from the University of Maryland.


Current positions of Merdad Parsey 
Holdings of Merdad Parsey 
Merdad Parsey : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/27ELON MUSK : human-like robots and self-driving cars
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/27BERNARD ARNAULT : LVMH has pricing power to counter inflation, but must be reasonable-Arnault
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/28CATHIE WOOD : Cathie Wood's ARK buys the dip in Tesla shares after months of selling
RE
01/26WILLIAM ACKMAN : Ackman's Pershing Square takes new position in Netflix
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
More news


© 2022 People and Ownership :   
Merdad Parsey : Connections 


Latest news about Merdad Parsey 
2021Gilead Says FDA Approves Expanded Indication of Biktarvy for Treatment of HIV-1 in Pediatric Populations
DJ
2021Gilead Submits NDA for Lenacapavir to U.S. FDA
DJ
2021Inside the race to find a COVID-19 treatment pill
RE
2021Inside the race to find a COVID-19 treatment pill
RE
2021GILEAD SCIENCES : Gets EU Approval to Bring Breast-Cancer Drug to Market
DJ
2021INSIDER TRENDS : Insider at Gilead Sciences Gets Share Award, Exercises Derivative Security, Makes Tax Sale with Portion
MT
2021Gilead forecasts 2021 growth, strong remdesivir COVID-19 sales
RE
More news